Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-11-05

FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approves a supplemental application for levetiracetam from Torrent Pharmaceuticals Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)